Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma

Eur Urol. 2018 Dec;74(6):842-843. doi: 10.1016/j.eururo.2018.08.011. Epub 2018 Aug 28.

Authors

Michael Staehler¹, Dena Battle², Axel Bex³, Hans Hammers⁴, Daniel George⁵

Affiliations

¹ University of Munich, Department of Urology, Multidisciplinary Center on Renal Tumors, Munich, Germany. Electronic address: michael.staehler@med.uni-muenchen.de.
² Kidney Cancer Research Alliance KCCure, VA, USA.
³ The Netherlands Cancer Institute, Division of Surgical Oncology, Urology, Amsterdam, The Netherlands.
⁴ UT Southwest, Medical Center, Dallas, TX, USA.
⁵ Duke Cancer Institute, Durham, NC, USA.

PMID: 30170873
DOI: 10.1016/j.eururo.2018.08.011

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Renal Cell / surgery*
Humans
Kidney Neoplasms / surgery
Nephrectomy
Sunitinib*

Substances

Sunitinib